Edition:
United Kingdom

AnGes Inc (4563.T)

4563.T on Tokyo Stock Exchange

512JPY
6:00am GMT
Change (% chg)

¥-13 (-2.48%)
Prev Close
¥525
Open
¥522
Day's High
¥524
Day's Low
¥509
Volume
961,600
Avg. Vol
2,162,356
52-wk High
¥884
52-wk Low
¥225

Latest Key Developments (Source: Significant Developments)

AnGes submits application for marketing approval for HGF gene therapy
Monday, 22 Jan 2018 

Jan 22 (Reuters) - AnGes Inc <4563.T> ::Says it submits application for marketing approval to Pharmaceuticals and Medical Devices Agency (PMDA) for HGF gene therapy for the treatment of critical limb ischemia (CLI).  Full Article

Anges MG says exercise of options
Tuesday, 23 May 2017 

May 23 (Reuters) - Anges MG Inc <4563.T>:* Says 9,000 units of its 29th series options were exercised to 900,000 shares of its common stock from May 1 to May 23.  Full Article

AnGes MG announces exercise of 10,300 options
Wednesday, 28 Sep 2016 

AnGes MG Inc <4563.T> :Says 10,300 of 28th warrants were exercised into 1.03 million shares of its common stock from Sept. 26 to Sept. 28, including 150,000 shares at exercise price 258 yen, 200,000 shares at 242 yen and 680,000 shares at 234 yen per share.  Full Article

AnGes MG announces exercise of 13,681 options
Friday, 23 Sep 2016 

AnGes MG Inc <4563.T> :Says 13,681 of 28th warrants were exercised into 1.37 million shares of its common stock from Sept. 16 to Sept. 23, including 150,000 shares at exercise price 209 yen and 200,000 shares at 206 yen etc..  Full Article

AnGes MG says exercise of warrants
Tuesday, 6 Sep 2016 

AnGes MG Inc <4563.T>:Says 7,800 of its 28th series warrants were exercised into 780,000 shares, during the period from Sep. 1 to Sep. 6.  Full Article

Anges MG announces exercise of options
Wednesday, 31 Aug 2016 

Anges MG Inc <4563.T>:Says 8,800 units of its 28th series options were exercised to 880,000 shares of its common stock from Aug. 23 to Aug. 30.  Full Article

Anges MG to work together with Vical Incorporated on DNA vaccine business
Friday, 12 Aug 2016 

Anges MG Inc <4563.T>:Says the company and Vical Incorporated has agreed to work together on DNA vaccine business, which includes research, development and manufacturing.  Full Article

AnGes MG to grant development manufacturing and marketing rights to Morishita Jintan
Thursday, 16 Jun 2016 

AnGes MG Inc <4563.T>: Says it reached basic agreement with Morishita Jintan Co Ltd <4524.T> on June 16 .Says it to grant exclusive development, manufacturing and marketing rights of cervical pre-cancer therapeutic vaccine to Morishita Jintan.  Full Article

AnGes MG announces exercise of warrants
Monday, 18 Apr 2016 

AnGes MG Inc:Says 64,367 of its 27th series warrants were exercised into 6,436,700 shares, during the period from April 12 to April 18.The shares exercised for 3,057,341,200 yen in total.  Full Article

AnGes MG announces exercise of warrants
Thursday, 14 Apr 2016 

AnGes MG Inc:Says 6,544 of its 27th series warrants were exercised into 654,400 shares at 435 yen per share, on April 14.  Full Article

BRIEF-AnGes submits application for marketing approval for HGF gene therapy

* Says it submits application for marketing approval to Pharmaceuticals and Medical Devices Agency (PMDA) for HGF gene therapy for the treatment of critical limb ischemia (CLI)